Special Issue

Anti-HLA DSA and Beyond: deciphering the immunological mechanisms driving chronic rejection

About this Special Issue

Despite the progress achieved over the last two decades in the field of therapeutic immunosuppression, immune-mediated destruction of allograft (aka chronic rejection) remains among the first causes of late failure. A better understanding of the mechanisms involved first in allorecognition and then in generating graft damages and allograft fibrosis, appears as a mandatory step to design future innovative therapeutic strategies with the potential to improve long-term outcomes.

This Special Issue of Transplant International gathers the best international experts to propose a synthesis of the latest advances in transplant immunology in the field of chronic rejection immunopathology.


Important
As a Gold open-access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.

Please see the following pages for:
Publishing Fees
Author Guidelines


Keywords: allograft, immunosuppression, allorecognition, allograft fibrosis


Despite the progress achieved over the last two decades in the field of therapeutic immunosuppression, immune-mediated destruction of allograft (aka chronic rejection) remains among the first causes of late failure. A better understanding of the mechanisms involved first in allorecognition and then in generating graft damages and allograft fibrosis, appears as a mandatory step to design future innovative therapeutic strategies with the potential to improve long-term outcomes.

This Special Issue of Transplant International gathers the best international experts to propose a synthesis of the latest advances in transplant immunology in the field of chronic rejection immunopathology.


Important
As a Gold open-access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.

Please see the following pages for:
Publishing Fees
Author Guidelines


Keywords: allograft, immunosuppression, allorecognition, allograft fibrosis


Issue Editors

Loading..

Participating Journals

Manuscripts can be submitted to this Special Issue via the following journals:

Loading..

Issue Editors

Loading..

Participating Journals

Manuscripts can be submitted to this Special Issue via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..
function trackUserViewItemGA4() { const dataLayer = (window).dataLayer; if (dataLayer) { dataLayer.push({ 'event': 'view_research_topic', 'research_topic_id': 49, 'research_topic_title': 'Anti-HLA DSA and Beyond: deciphering the immunological mechanisms driving chronic rejection', 'journal_id': 9, 'journal_title': 'Transplant International', 'section_title': '', 'section_id': 0, }); } } $(window).load(function () { trackUserViewItemGA4(); });